SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft.The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SPCX is experiencing extreme volatility following its massive IPO as investors debate the impact of the newly announced $60 billion all-stock acquisition of AI startup Cursor. Community discussion remains polarized, with bulls betting on aggressive growth and Elon Musk's long-term vision, while skeptics are pointing to significant dilution concerns, the lack of current profitability, and a tight initial float that has created a hot-potato environment.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is under heavy community scrutiny as investors brace for the final data readout from its Phase 3 REGAL trial, with intense debate centered on the upcoming vote for a 20 million share RSU expansion. While bulls argue that the extended trial duration and recent protocol adjustments indicate strong patient survival and a potentially curative treatment for AML, bears and skeptics are voicing significant concerns regarding potential shareholder dilution and the historical failure of similar cancer vaccine programs.

Rackspace Technology, Inc. engages in the provision of end-to-end multi-cloud technology services. The firm designs, builds and operates its customers’ cloud environments across technology platforms. It operates through the following segments: Multicloud Services and Apps & Cross Platform. The Multicloud Services segment includes public and private cloud managed services offerings, as well as professional services related to designing and building multicloud solutions and cloud-native applications. The Apps & Cross Platform segment includes managed applications, managed security and data services, as well as professional services related to designing and implementing application, security and data services. The company was founded on July 21, 2016 and is headquartered in San Antonio, TX.

Rackspace Technology Inc

Rackspace Technology is trending as shares surge following a 15% workforce reduction to reinvest in AI and a major deal with AMD for the phased deployment of an AI compute footprint. Investors are actively discussing the growth potential of this AI-focused pivot, with community sentiment split between excitement over the contract's scale and debates regarding the company's debt and potential for future share offerings.

Dave & Buster's Entertainment, Inc. engages in the ownership and operation of entertainment and dining venues under the name Dave & Buster's. It offers a full menu of entrées and appetizers, a selection of alcoholic and non-alcoholic beverages, and an assortment of entertainment attractions centered around playing games and watching live sports and other televised events. The company was founded by David O. Corriveau and James W. Corley in 1982 and is headquartered in Coppell, TX.

Dave & Buster`s Entertainment Inc

Dave & Buster's Entertainment

Dave & Buster's is facing significant downward pressure following a disappointing quarterly earnings report that missed both revenue and EPS estimates, fueling community speculation about the company's financial stability. While some investors view the current beaten-down price as a potential deep-value buying opportunity, the broader community remains divided, with active discussions focusing on concerns over debt levels, management strategy, and whether a turnaround is realistic.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy Enterprises is trending as investors react to a major strategic framework agreement involving Frontier Power USA and Stella Energy Solutions, which aims to convert a significant project pipeline into long-term demand for its zinc-based storage technology. Despite volatility and intense short interest, the community is actively debating the stock's potential as a critical AI infrastructure play, focusing on the company's recent earnings beat, production scaling at its Thorn Hill facility, and the broader grid-scale energy storage demand.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is experiencing significant momentum driven by robust institutional demand for high-capacity storage, particularly as hyperscale data centers scramble to secure supply for artificial intelligence workloads. The community remains highly focused on the storage sector's massive cyclical turnaround, with active discussions debating whether the stock's recent ascent represents a sustainable re-rating tied to pricing power or a speculative bubble reminiscent of past tech cycles.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending as investors weigh potential new vaccine development opportunities amid recent global health headlines regarding emerging viral outbreaks. The community is actively debating the company's long-term oncology pipeline and the impact of broader biotech sector volatility on its market performance.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. The company operates through the OSS and OSS Europe segments. One Stop Systems was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is surging following an earnings report that highlighted record bookings, double-digit revenue growth, and a strong pipeline in Edge AI and defense sectors. The community is actively discussing the company's expansion into mission-critical military applications, with many investors anticipating long-term valuation growth driven by a solid cash position and upcoming potential defense contracts.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is drawing significant attention as investors anticipate a major update regarding its AR Spectacles during a highly awaited keynote at the Augmented World Expo. While the community remains divided over the stock's long-term valuation and management's effectiveness, many are closely watching for potential hardware breakthroughs or strategic partnerships that could catalyze a shift in momentum.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies Inc

Rocket Companies is gaining momentum as investors weigh a strong earnings beat and a resilient business model against persistent macroeconomic headwinds like high interest rates. The community is actively debating whether the stock is a cyclical mortgage play or a long-term platform play, with many watching for potential upside if the 10-year yield stabilizes or policy shifts favor housing market activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Perceptive Advisors Llc Sells 31,810 Shares of Lyra Therapeutics (NASDAQ:LYRA) Stock

Lyra Therapeutics, Inc. (NASDAQ:LYRA - Get Free Report) major shareholder Perceptive Advisors Llc sold 31,810 shares of the stock in a transaction on Thursday, November 13th. The stock was sold at an...

Lyra Therapeutics, Inc. (LYRA) Reports Q3 Loss, Lags Revenue Estimates

Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of +43.48% and -77.27%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Lyra Therapeutics (NASDAQ:LYRA) Major Shareholder Perceptive Advisors Llc Sells 32,149 Shares

Lyra Therapeutics, Inc. (NASDAQ:LYRA - Get Free Report) major shareholder Perceptive Advisors Llc sold 32,149 shares of Lyra Therapeutics stock in a transaction on Thursday, November 6th. The shares...

Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates

Assertio (ASRT) delivered earnings and revenue surprises of +237.50% and +83.86%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Dentsply International (XRAY) Lags Q3 Earnings Estimates

Dentsply (XRAY) delivered earnings and revenue surprises of -17.78% and +0.27%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -150.00% and -0.91%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Lyra Therapeutics To Conduct One More Trial For Chronic Rhinosinusitis Treatment Candidate

Equity

The company stated that the design of the new trial will be based on the learnings from the previous trials, in addition to FDA feedback.

Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates

Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of +4.84% and +26.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -100.00% and -1.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Lyra Therapeutics (LYRA) Upgraded to Buy: Here's Why

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat (ENT) diseases. The firm's proprietary XTreo platform delivers medicines directly to targeted sites. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer on November 21, 2005 and is headquartered in Watertown, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$2.59	--	--	N/A
Q3 '25	-$5.26	-$3.38	35.68%	BEAT
Q2 '25	-$5.53	-$5.51	0.30%	BEAT
Q1 '25	-$0.15	-$6.50	-4233.33%	MISSED
Q4 '24	-$0.12	-$0.16	-33.33%	MISSED

LYRALyra Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest LYRA News